BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14689878)

  • 1. [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].
    Kikuchi T; Miyata A; Fujii S; Kikuchi T
    Rinsho Ketsueki; 2003 Nov; 44(11):1113-6. PubMed ID: 14689878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Successful recovery of an acute myelogenous leukemia patient from a coma possibly due to leukoencephalopathy].
    Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2003 Nov; 44(11):1090-4. PubMed ID: 14689873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.
    Ruutu T; Koivunen E; Nousiainen T; Pelliniemi TT; Almqvist A; Anttila P; Jantunen E; Koistinen P; Koponen A; Mikkola M; Oksanen K; Pulli T; Remes K; Sarkkinen R; Silvennoinen R; Timonen T; Vanhatalo S; Elonen E;
    Eur J Haematol; 2004 Jan; 72(1):38-44. PubMed ID: 14962261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].
    Yoshida K; Kusumoto S; Sugahara Y; Yagasaki F; Sakata T; Kawai N; Matsuda A; Suzuki T; Hirashima K; Kayano H; Bessho M
    Rinsho Ketsueki; 2001 Aug; 42(8):644-9. PubMed ID: 11579505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK; Heil G; Zander C; Wiebe S; Ottmann OG; Bergmann L; Hoeffken K; Fischer JT; Knuth A; Kolbe K; Schmoll HJ; Langer W; Westerhausen M; Koelbel CB; Hoelzer D; Ganser A
    Ann Hematol; 2004 Aug; 83(8):498-503. PubMed ID: 15156346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction.
    Farah RA; Jalkh KS; Farhat HZ; Sayad PE; Kadri AM
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):140-3. PubMed ID: 21178585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.
    Alymara V; Tzouvara E; Vartholomatos G; Chaidos A; Tsiara S; Bourantas KL
    J Exp Clin Cancer Res; 2004 Sep; 23(3):447-54. PubMed ID: 15595635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
    Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
    Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].
    Yata K; Yamada O; Iwato K; Kyo T; Otsuki T; Nakanishi H; Suetsugu Y; Mikami M; Wada H; Yawata Y; Sugihara T
    Rinsho Ketsueki; 2002 Jan; 43(1):41-3. PubMed ID: 11868364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute monoblastic leukemia complicated by fatal splenic rupture following initiation of chemotherapy].
    Borgeat A; Tran-Thang C; Bachmann F
    Schweiz Med Wochenschr; 1989 Feb; 119(7):227-9. PubMed ID: 2711160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute myelogenous leukemia developed at the 26th week of gestation].
    Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N
    Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.
    Giles FJ; Kantarjian HM; Cortes JE; Faderl S; Verstovsek S; Thomas D; Garcia-Manero G; Wierda W; Ferrajoli A; Kornblau S; Mattiuzzi GN; Tsimberidou AM; Albitar M; O'Brien SM; Estey E
    Leuk Res; 2005 Jun; 29(6):649-52. PubMed ID: 15863204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
    HoĊ‚owiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
    Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient].
    Yamasaki J; Hata T; Fuchigami K; Togami K; Honda M; Fukushima T; Miyazaki Y; Jinnai I; Kuriyama K; Tomonaga M
    Rinsho Ketsueki; 2003 Oct; 44(10):1015-9. PubMed ID: 14639948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two cases of acute myelogenous leukemia complicated with fatal gastrointestinal tract bleeding after treatment with idarubicin and cytarabine].
    Nagashima T; Izumi T; Muroi K; Miyasato A; Uchida M; Imagawa S; Komatsu N; Yoshida M; Hatake K; Miura Y; Ozawa K
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):487-90. PubMed ID: 10740646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
    He H; Li C; Han M
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.